ijms-logo

Journal Browser

Journal Browser

Vitamin D and New Vitamin D Analogs

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Bioactives and Nutraceuticals".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 38

Special Issue Editor


E-Mail Website
Guest Editor
Departamento de Química Orgánica, Facultad de Química y IIS Galicia Sur Edificio Ciencias Experimentales Universidad de Vigo, 36200 Vigo, Spain
Interests: vitamin D; medicinal chemistry; organic chemistry synthesis; ionic liquids synthesis; bioactive compounds

Special Issue Information

Dear Colleagues,

The active form of Vitamin D3, 1α, 25-dihydroxyvitamin D3 (1,25 D or calcitriol), exerts its biological functions by binding to the vitamin D receptor (VDR), a transcription factor of the nuclear receptor (NR) superfamily. Calcitriol was known for many years as a primary regulator of calcium homeostasis, but it also controls a wide range of other biological functions, including cell differentiation, cell proliferation, and immune responses. It induces the expression of more than 200 genes associated with several diseases such as arthritis, diabetes, and cancer, suggesting that this hormone might induce a wide range of biological functions. Unfortunately, 1,25D induces hypercalcemia at the doses required for the treatment of hyperproliferative diseases such as cancer. This limitation has led to intense synthetic efforts towards VDR ligands with selective activities as potential therapeutic agents for the treatment of cancer, immunodeficiency syndromes, autoimmune diseases, and skin disorders. Calcipotriol and maxacalcitol, examples of 1,25D analogs with a modified side-chain, exhibit a similar or higher antiproliferative potency with reduced calcemic effects in comparison with natural hormone 1,25D. Other potent 1,25D analogs structurally modified at the CD-rings or triene system that induce low potency for calcium metabolism have also been synthesized. 1,25D therapeutic doses promote calcium absorption, leading to hypercalcemia. More than 4000 vitamin D analogs have been synthesized to dissociate the hypercalcemic effect from the anti-inflammatory and/or antiproliferative activities, but only a few of them have reached clinical application. There is accordingly still much interest in the design and synthesis of new calcitriol analogs exhibiting high cell-differentiating properties coupled with low or negligible calcemic effects.

Prof. Dr. Yagamare Fall
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vitamin D
  • vitamin D receptor
  • vitamin D analogs
  • synthesis
  • clinical applications
  • cancer
  • anti-proliferation
  • therapeutic target

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop